Small molecule drug release from in situ forming degradable scaffolds incorporating hydrogels and bioceramic microparticles
US-2015290361-A1 · Oct 15, 2015 · US
US10632227B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10632227-B2 |
| Application number | US-201615548389-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 8, 2016 |
| Priority date | Feb 9, 2015 |
| Publication date | Apr 28, 2020 |
| Grant date | Apr 28, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A discovery of the conversion of amorphous calcium polyphosphate (ACPP) or/and other polyphosphate salts with various type of calcium phosphate to new calcium phosphate product (i.e. dicalcium phosphate dihydrate (DCPD)) in a liquid environment. The discovery includes mixing a various type of calcium phosphate with an aqueous ACPP or/and other polyphosphate salts gel, which is fast setting and possessing strong mechanical strength, and can be gradually converted to DCPD/hydroxyapatites in physiological condition. This injectable past can be applied as alternative of conventional CPC bone cement that is suitable for bone void repair due to its excellent properties in osteoconductivity and osseointegration. It can also be applied as drug delivery device in tissue engineering for its strong bonding to drug molecules.
Opening claim text (preview).
The invention claimed is: 1. A cement comprising: a hydrogel including a polyphosphate selected from the group consisting of sodium polyphosphate, potassium polyphosphate, calcium polyphosphate, strontium polyphosphate, magnesium polyphosphate, aluminum polyphosphate, zinc polyphosphate, copper polyphosphate, cadmium polyphosphate, manganese polyphosphate, and ammonium polyphosphate, and tetracalcium phosphate, wherein a ratio of the hydrogel to tetracalcium phosphate is 1:0.1 to 1:10 by weight, wherein the cement is injectable and has a mechanical strength for a bone repair application. 2. The cement of claim 1 , wherein the cement has a setting mechanism comprising reaction of dehydration of the hydrogel. 3. The cement of claim 1 wherein the polyphosphate has a degree of polymerization of at least about 2. 4. The cement of claim 1 wherein the mechanical strength comprises a compressive strength of between about 5 megapascal and about 200 megapascal. 5. The cement of claim 1 further comprising at least one of an inorganic filler and an organic filler. 6. The cement of claim 5 wherein the inorganic filler comprises at least one of a bioglass, a silica ceramic, an oxide ceramic, a carbon fiber, a metal, and a metal alloy. 7. The cement of claim 5 wherein the inorganic filler comprises a powder having a particle size of about 1 nanometer to about 1000 micrometers. 8. The cement of claim 5 comprising at least one of a polycarboxylate, a polysulfate, polysulfonates, a polyphosphate, a polyamine, a polyurea, a polyamide, a polyalkylene oxide diol, a polyalkylene oxide diamine, a polycarbonate, a polylactone, a polyethersulfone, a polyvinyl, a polypeptide, a polysaccharide, a polyurethane, a polysulfone, a polyester, polyethylene, polypropylene, polystyrene, polysilicone, poly(acrylonitrile-butadienestyrene), polybutadiene, polyisoprene, polymethylmethacrylate, polyvinylacetate, polyacrylonitrile, polyvinyl chloride, polyethylene terephtalate, cellulose, a polysilicone, a polyolefin, a polyvinyl derivative, a polypeptide derivative, poly(lactic-co-glycolic acid), and a polysaccharide derivative. 9. The cement of claim 5 , comprising at least one of a carboxylate, a sulfate, a sulfonate, a phosphate, an amine, urea, an amide, an alkylene oxide diol, an alkylene oxide diamine, a carbonate, a lactone, an ethersulfone, a vinyl, a peptide, a dimethacrylate, a saccharide, a urethane, a sulfone, an ester, an ethylene, propylene, a styrene, silicone, acrylonitrile-butadienestyrene, butadiene, an isoprene, methylmethacrylate, vinylacetate, acrylonitrile, vinyl chloride, ethylene terephtalate, an olefin, a vinyl derivative, bisphenol A, a bisphenol A derivative, an oligosaccharide, a peptide derivative, lactic acid, glycolic acid, cyanoacrylate, a cyanoacrylate derivative, and a saccharide derivative. 10. The cement of claim 1 having a setting time from 1 minute to about 30 minutes. 11. The cement of claim 1 having a ratio of calcium to phosphate of about 1:10 to about 10:1. 12. The cement of claim 1 , wherein the polyphosphate is an amorphous polyphosphate. 13. The cement of claim 12 , comprising amorphous calcium polyphosphate. 14. The cement of claim 1 , wherein the ratio is 1:0.15 to 1:1. 15. A method of making an injectable bone cement, the method comprising: gelating a polyphosphate compound in aqueous solution to form a hydrogel, the polyphosphate compound being selected from the group consisting of sodium polyphosphate, potassium polyphosphate, calcium polyphosphate, strontium polyphosphate, magnesium polyphosphate, aluminum polyphosphate, zinc polyphosphate, copper polyphosphate, cadmium polyphosphate, manganese polyphosphate, ammonium polyphosphate; and reacting the hydrogel with tetracalcium phosphate wherein the ratio of the hydrogel to tetracalcium phosphate is 1:0.1 to 1:10 by weight, to form the injectable bone cement. 16. The method of claim 15 further comprising mixing a filler material with the polyphosphate compound, the filler material comprising at least one of an inorganic material and an organic material. 17. The method of claim 15 , wherein the first polyphosphate compound comprises amorphous calcium polyphosphate. 18. The method of claim 15 , comprising at least one of a polycarboxylate, a polysulfate, polysulfonates, a polyphosphate, a polyamine, a polyurea, a polyamide, a polyalkylene oxide diol, a polyalkylene oxide diamine, a polycarbonate, a polylactone, a polyethersulfone, a polyvinyl, a polypeptide, a polysaccharide, a polyurethane, a polysulfone, a polyester, polyethylene, polypropylene, polystyrene, polysilicone, poly(acrylonitrile-butadienestyrene), polybutadiene, polyisoprene, polymethylmethacrylate, polyvinylacetate, polyacrylonitrile, polyvinyl chloride, polyethylene terephtalate, cellulose, a polysilicone, a polyolefin, a polyvinyl derivative, a polypeptide derivative, poly(lactic-co-glycolic acid), and a polysaccharide derivative. 19. The method of claim 15 , comprising at least one of a carboxylate, a sulfate, a sulfonate, a phosphate, an amine, urea, an amide, an alkylene oxide diol, an alkylene oxide diamine, a carbonate, a lactone, an ethersulfone, a vinyl, a peptide, a dimethacrylate, a saccharide, a urethane, a sulfone, an ester, an ethylene, propylene, a styrene, silicone, acrylonitrile-butadienestyrene, butadiene, an isoprene, methylmethacrylate, vinylacetate, acrylonitrile, vinyl chloride, ethylene terephtalate, an olefin, a vinyl derivative, bisphenol A, a bisphenol A derivative, an oligosaccharide, a peptide derivative, lactic acid, glycolic acid, cyanoacrylate, a cyanoacrylate derivative, and a saccharide derivative. 20. The method of claim 15 , wherein the ratio is1:0.15 to 1:1.
Phosphorus containing materials, e.g. apatite · CPC title
containing cold phosphate binders · CPC title
Flowable or injectable implant compositions · CPC title
with an inorganic matrix · CPC title
containing inorganic materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.